{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "CMCO",
  "name": "Columbus McKinnon Corporation",
  "url": "https://orbyd.app/dossiers/CMCO/",
  "json_url": "https://orbyd.app/dossiers/CMCO.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "First full combined quarter post-Kito Crosby beat hard (adj EPS $0.61 vs $0.27 est) and drove a guidance raise on all three lines on 2026-07-30; the leg being bought is deleveraging from 4.9x toward sub-4x by FY28 on $70M of synergies. No company catalyst until the ~late-Oct Q2 print, with price 12.1% off the $23.01 high.",
  "invalidation_trigger": "A daily close below $18.50 hands back the 2026-07-30 guidance-raise shelf; secondary break is a Q2 FY27 print (~2026-10-29, est.) showing Credit Agreement Net Leverage above 4.9x, book-to-bill under 1.0x, or a cut to the $2.09–2.15B FY27 sales guide.",
  "catalyst_date": "2026-08-14",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "cyclical-industrials"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Fiscal year ends March 31: \"Q1 FY27\" is the quarter ended 2026-06-30 and \"FY27\" the year ending 2027-03-31.",
    "Purchase accounting from the 2026-02-03 Kito Crosby close keeps GAAP and adjusted results far apart; FY27 amortization is guided at $135-140M.",
    "CD&R holds $800M of Series A cumulative convertible participating preferred (7.0%, $37.68 conversion) plus three of twelve board seats.",
    "The FTC-required divestiture of U.S. power chain hoist and chain manufacturing closed 2026-03-04, distorting YoY revenue comparisons through FY27.",
    "Capital structure since February 2026: $1.65B Term Loan B (floating), $900M 7.125% senior secured notes due 2033, $500M revolver."
  ],
  "body_markdown": "## Current Thesis\n\nThe leg on offer is a levered-integration re-rating. Columbus McKinnon closed the $2.7B cash acquisition of Kito Crosby on 2026-02-03, and the quarter ended 2026-06-30 was the first full period as a combined company: net sales $531.5M (+125% YoY), orders $568.1M (+120% YoY), book-to-bill 1.1x, adjusted EBITDA $111.5M at a 21.0% margin (+720bps YoY). Management raised FY27 (year ending 2027-03-31) guidance on 2026-07-30 across all three lines — sales to $2.09–2.15B from $2.05–2.12B, adjusted EBITDA to $405–420M from $390–410M, adjusted EPS to $1.90–2.10 from $1.70–1.90 against a $1.75 consensus. What an investor is buying is the arithmetic of deleveraging: Credit Agreement Net Leverage of 4.9x at quarter-end against a stated path below 4x by FY28, funded by $70M of targeted annual run-rate synergies. Every turn of leverage retired transfers value from the debt stack to the equity stub. The corollary is that the equity is a spread trade on execution, priced off a $185–190M FY27 interest expense line that does not flex with demand.\n\n## Bull Case\n\n- **The first combined print cleared the bar by a wide margin.** Adjusted EPS $0.61 vs $0.27 consensus and sales $531.461M vs $501.262M consensus (2026-07-30). Adjusted net income $30.5M, +114% YoY.\n- **Demand is not the constraint right now.** Orders of $568.1M exceeded sales of $531.5M for a 1.1x book-to-bill in the June quarter; legacy Columbus McKinnon net sales grew 12.7%, which CEO David Wilson attributed to U.S. short-cycle demand on the 2026-07-30 release.\n- **Margin is expanding on two engines at once.** Adjusted gross margin 38.1% (+380bps YoY) and adjusted EBITDA margin 21.0% (+720bps YoY). CFO John Linker named the Kito Crosby mix, synergy realization and material-cost benefits as the drivers.\n- **The synergy target has room above it.** Management signalled increasing confidence in exceeding the original $70M annual run-rate cost target, with Q1 capture weighted to SG&A — the manufacturing and procurement tranches are still ahead rather than spent.\n- **Guidance was raised on all three lines in one release**, and the adjusted EPS guide is struck on stated assumptions of 52M adjusted diluted shares, $135–140M amortization, $75–80M depreciation and a 25% normalized tax rate (2026-07-30). Those assumptions are checkable at the next print.\n- **Sell-side is not uniformly positioned.** J.P. Morgan (James Kirby) maintained Overweight and raised its target to $29 from $25 on 2026-07-31 — roughly 43% above the 2026-08-07 close of $20.22.\n\n## Bear Case\n\n- **GAAP does not look like the adjusted deck.** The June quarter produced a GAAP net loss of $88.7M, or −$2.05 per diluted share, against $30.5M of adjusted net income. With $135–140M of FY27 amortization guided, the reported line stays impaired for years and screens built on GAAP earnings keep excluding the name.\n- **4.9x is a real number.** Credit Agreement Net Leverage of 4.9x at 2026-06-30 sits on $1.65B of Term Loan B, $900M of 7.125% senior secured notes due 2033 and a $500M revolver. The FY27 interest assumption of $185–190M is roughly 45% of the midpoint adjusted EBITDA guide.\n- **Cash conversion has not yet arrived.** Q1 operating cash flow was $25.6M and free cash flow $20.0M ($32.4M excluding deal costs) against $111.5M of adjusted EBITDA. Deleveraging requires that gap to close over the balance of FY27.\n- **The preferred sits above the common.** CD&R holds 800,000 Series A cumulative convertible participating preferred shares issued for $800.0M at a 7.0% dividend, converting at $37.68, plus three of twelve board seats (financing completed alongside the 2026-02-03 close). That dividend accrues ahead of the common regardless of how the operating year goes.\n- **The comparison base is engineered.** Kito Crosby contributed $304.8M of the $531.5M in Q1, and the FTC-required divestiture of U.S. power chain hoist and chain manufacturing closed 2026-03-04, so YoY growth optics stay distorted through FY27.\n- **Coverage is dispersed rather than converged.** Against J.P. Morgan's $29, DA Davidson (Matt Summerville) is carried at Neutral with an $18 target per a StreetInsider analyst-PT-change entry in the first week of August 2026 — below the 2026-08-07 close. Two firms reading the same print land roughly 60% apart on fair value.\n\n## Setup & Price Structure\n\nOn the pipeline's split- and dividend-adjusted basis as of 2026-08-07, the last completed daily close was $20.22, the 52-week high $23.01, and price sits 12.1% under that high after a +27.3% three-month return. RSI(14) reads 69.3.\n\nThat combination is what to sit with: momentum still reads hot while price has already surrendered a meaningful slice of the move off the high. INFERRED, not measured — with the 2026-07-30 guidance raise a handful of sessions back and a +27.3% quarter behind it, the $23.01 high most plausibly sits inside the post-earnings window, which makes the $20.22 close a giveback of the initial reaction rather than a base that has been tested.\n\n**Life-cycle: ACCELERATING.** What dates it: the 2026-07-30 first-full-combined-quarter beat and guidance raise; the same-day cluster of Benzinga movers coverage (three separate pre-market and intraday industrial-mover items on 2026-07-30); the J.P. Morgan target raise to $29 on 2026-07-31. This is fresh attention on a company whose revenue base more than doubled six months ago and which most industrial screens have not re-underwritten. The counter-evidence against the label is the 12.1% distance from the high and an $18 Neutral target still standing after the print — flow moderated inside two weeks of the catalyst.\n\n**Crowding and positioning observables**, stated as observables and not as a verdict: RSI(14) 69.3 with price 12.1% below the 52-week high; a +27.3% three-month advance; no company-scheduled catalyst inside the next 30 days beyond the annual meeting; a sell-side target range spanning $18 to $29 around a $20.22 close; an $800M private-equity preferred whose $37.68 conversion price sits far above spot. No insider transaction data appears in the filing feed for this window, so no claim is made in either direction on insider activity.\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-08-14** — 2026 Annual Meeting of Shareholders, held virtually at 9:00 a.m. ET per the company's proxy solicitation materials. Routine in expectation; the substantive item is the board as reconstituted at twelve directors including three CD&R designees.\n- **~2026-09-01 (est.)** — ISM Manufacturing PMI for August, released on the first business day of the month. Legacy Columbus McKinnon's 12.7% growth was explicitly tied to U.S. short-cycle demand; the new-orders sub-index is the cleanest public read on whether that persisted.\n- **Beyond the window: ~2026-10-29 (est.)** — Q2 FY27 print. First opportunity to mark the 4.9x leverage ratio, the $70M synergy run-rate and the raised $2.09–2.15B sales guide against a second combined quarter. Nothing between now and then resolves the thesis.\n\n## What Would Change Our Mind\n\nThe structure that matters is the shelf built by the 2026-07-30 reaction, and it has not yet been retested. A daily close below $18.50 — roughly 20% under the $23.01 52-week high — would say the market handed back the guidance raise in full and that the +27.3% three-month advance was a re-rating that failed to hold. That is the gradeable break.\n\nThe fundamental break is separate and slower. At the Q2 FY27 print (~2026-10-29, est.), a Credit Agreement Net Leverage ratio printing above the 4.9x reported at 2026-06-30, a book-to-bill under 1.0x, or any trim to the $2.09–2.15B sales guide would each undercut the deleveraging arithmetic the equity is being paid for. Cutting the $70M run-rate synergy target, or pushing the sub-4x-by-FY28 leverage goal into FY29, does the same damage without touching the revenue line. In the other direction, free cash flow converting toward the $111.5M quarterly adjusted EBITDA run-rate would strengthen the case materially — Q1's $20.0M is the number to beat.\n\nThe passive failure mode is the 2026-08-14 annual meeting coming and going with no new disclosure and no fresh sell-side work, leaving roughly eleven weeks of empty calendar into late October. A name 12.1% off its high with RSI at 69.3 and no scheduled catalyst has to hold on flow alone.\n\n## Correlation Notes\n\n- **Interest-rate path feeds the P&L directly.** The $1.65B Term Loan B is floating-rate; the $900M of 7.125% notes due 2033 is not. Front-end expectations move the $185–190M FY27 interest guide, the single largest claim on adjusted EBITDA.\n- **Short-cycle industrial complex.** The demand signal is shared with Enerpac (EPAC), Kadant (KAI), Terex (TEX) and Manitowoc (MTW); order rates and book-to-bill matter more than reported revenue given backlog conversion lag.\n- **Small-cap levered beta.** A capital structure at 4.9x behaves partly like credit — Russell 2000 drawdowns and high-yield spread widening transmit harder here than at an unlevered industrial of comparable size.\n- **Steel, chain and tariff inputs.** \"Benefits to material costs\" was named as a Q1 margin driver on 2026-07-30; a reversal in steel or a tariff change on imported chain and rigging components pressures the 38.1% adjusted gross margin from the cost side.\n- **Private-equity overhang.** CD&R's $800M preferred converts at $37.68 and pays 7.0%. Movement in the common toward that conversion price changes the effective share count the market underwrites — a sensitivity a plain-vanilla industrial does not carry.",
  "first_seen": "2026-07-31",
  "last_analyzed": "2026-08-09T08:10:07+00:00",
  "last_synthesized": "2026-08-08",
  "last_update_source": "theme_discovery",
  "license": "Content © orbyd. Cite the canonical URL."
}